Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 14/20 | 0.49 |
| ▸ | JAK2 | O60674 | 13/20 | 0.49 |
| ▸ | JAK1 | P23458 | 13/20 | 0.49 |
| ▸ | TYK2 | P29597 | 5/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27419216 | 1.00 | JAK3 (0.49) | JAK3JAK2JAK1TYK2EGFR | |
| SCHEMBL27418945 | 0.93 | JAK1 (0.43) | JAK3JAK2JAK1TYK2USP2 | |
| SCHEMBL27419238 | 0.91 | JAK3 (0.51) | JAK3JAK2JAK1TYK2EGFR | |
| SCHEMBL31711618 | 0.91 | JAK3 (0.51) | JAK3JAK2JAK1TYK2EGFR | |
| SCHEMBL31711624 | 0.91 | JAK3 (0.59) | JAK3JAK2JAK1TYK2 | |
| SCHEMBL27414755 | 0.91 | JAK3 (0.59) | JAK3JAK2JAK1TYK2 | |
| SCHEMBL27419078 | 0.91 | JAK3 (0.50) | JAK3JAK2JAK1TYK2USP2 | |
| SCHEMBL27418707 | 0.90 | JAK3 (0.50) | JAK3JAK2JAK1TYK2USP2 | |
| SCHEMBL27418635 | 0.90 | JAK3 (0.50) | JAK3JAK2JAK1TYK2USP2 | |
| SCHEMBL27418552 | 0.90 | JAK1 (0.46) | JAK3JAK2JAK1TYK2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637738-A2 | INHIBITORS OF JAK2 | Llydaw Therapeutics, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |